ID: ALA5271974

Max Phase: Preclinical

Molecular Formula: C16H21N7

Molecular Weight: 311.39

Associated Items:

Representations

Canonical SMILES:  CN(C)CCCNc1nc(N)nc2cc(-c3ccccc3)nn12

Standard InChI:  InChI=1S/C16H21N7/c1-22(2)10-6-9-18-16-20-15(17)19-14-11-13(21-23(14)16)12-7-4-3-5-8-12/h3-5,7-8,11H,6,9-10H2,1-2H3,(H3,17,18,19,20)

Standard InChI Key:  WICDHIIRVNIUEM-UHFFFAOYSA-N

Associated Targets(Human)

Calcitonin gene-related peptide 1 214 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 311.39Molecular Weight (Monoisotopic): 311.1858AlogP: 1.74#Rotatable Bonds: 6
Polar Surface Area: 84.37Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.40CX LogP: 2.09CX LogD: 0.10
Aromatic Rings: 3Heavy Atoms: 23QED Weighted: 0.67Np Likeness Score: -1.68

References

1. Alizadeh SR, Ebrahimzadeh MA..  (2021)  Pyrazolotriazines: Biological activities, synthetic strategies and recent developments.,  223  [PMID:34147747] [10.1016/j.ejmech.2021.113537]

Source